Remove 2014 Remove Doctors Remove Healthcare Provider Remove Specialization
article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs. Biogen’s activity in multiple sclerosis.

article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

Furthermore, entire value chains must be redesigned and the CO 2 emitters (especially point source emitters), chemical industry and power sector, downstream users, eg, healthcare industries and their customers, and healthcare providers need to be coordinated, informed, sensitised and must work out contractual frameworks to de-risk the investments.

article thumbnail

Liron Fendell

Cadensee

Liron Fendell is the CEO of Nutritional Growth Solutions, or NGS, that specializes in scientific supplement formulas for children of a small stature. Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. They want it to be backed by doctors. Liron Fendell. CEO, nutritional growth solutions.

Retail 52